These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26394019)

  • 1. Microparticulate and nanoparticulate drug delivery systems for metformin hydrochloride.
    Cetin M; Sahin S
    Drug Deliv; 2016 Oct; 23(8):2796-2805. PubMed ID: 26394019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin hydrochloride and wound healing: from nanoformulation to pharmacological evaluation.
    El-Ridy MS; Yehia SA; Elsayed I; Younis MM; Abdel-Rahman RF; El-Gamil MA
    J Liposome Res; 2019 Dec; 29(4):343-356. PubMed ID: 30526146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and evaluation of novel solid lipid microparticles as a sustained release system for the delivery of metformin hydrochloride.
    Momoh MA; Kenechukwu FC; Attama AA
    Drug Deliv; 2013; 20(3-4):102-11. PubMed ID: 23650987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Characterization of Metformin Loaded Pectin Nanoparticles for T2 Diabetes Mellitus.
    Chinnaiyan SK; Karthikeyan D; Gadela VR
    Pharm Nanotechnol; 2018; 6(4):253-263. PubMed ID: 30574859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Characterization of Metformin-Loaded Solid Lipid Nanoparticles for Colon Cancer.
    Ngwuluka NC; Kotak DJ; Devarajan PV
    AAPS PharmSciTech; 2017 Feb; 18(2):358-368. PubMed ID: 26975870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchronized and controlled release of metformin hydrochloride/glipizide from elementary osmotic delivery.
    Pan H; Jing H; Yang X; Pan W; Chen T
    Drug Dev Ind Pharm; 2017 May; 43(5):780-788. PubMed ID: 27278057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of metformin hydrochloride loaded-Eudragit®RSPO and Eudragit®RSPO/PLGA nanoparticles.
    Cetin M; Atila A; Sahin S; Vural I
    Pharm Dev Technol; 2013; 18(3):570-6. PubMed ID: 21864098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Formulation by design of experiments of immediate release tablets with metformin hydrochloride and glibenclamide].
    Potur RG; Gafiţanu E
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1219-26. PubMed ID: 21500483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of spray dried bioadhesive metformin microparticles for oromucosal administration.
    Sander C; Madsen KD; Hyrup B; Nielsen HM; Rantanen J; Jacobsen J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):682-8. PubMed ID: 23774184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(3-4):167-84. PubMed ID: 23457958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulin.
    Wong CY; Al-Salami H; Dass CR
    Int J Pharm; 2018 Feb; 537(1-2):223-244. PubMed ID: 29288095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system.
    Hasan AA; Madkor H; Wageh S
    Drug Deliv; 2013; 20(3-4):120-6. PubMed ID: 23651102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged release of metformin by SiO
    Patiño-Herrera R; Louvier-Hernández JF; Escamilla-Silva EM; Chaumel J; Escobedo AGP; Pérez E
    Eur J Pharm Sci; 2019 Apr; 131():1-8. PubMed ID: 30735819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmucosal delivery of metformin- a comprehensive study.
    Sushma M; Raju YP; Sundaresan CR; Vandana KR; Kumar NV; Chowdary VH
    Curr Drug Deliv; 2014; 11(2):172-8. PubMed ID: 23848354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastro-floating bilayer tablets for the sustained release of metformin and immediate release of pioglitazone: preparation and in vitro/in vivo evaluation.
    He W; Li Y; Zhang R; Wu Z; Yin L
    Int J Pharm; 2014 Dec; 476(1-2):223-31. PubMed ID: 25283698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extemporaneous Formulations of Metformin for Pediatric Endocrinology: Physicochemical Integrity, Cytotoxicity of Sweeteners, and Quantitation of Plasma Levels.
    Alemón-Medina R; Chávez-Pacheco JL; Rivera-Espinosa L; Ramírez-Mendiola B; García-Álvarez R; Sámano-Salazar C; Manuel Dávila-Borja V
    Clin Ther; 2015 Aug; 37(8):1689-702. PubMed ID: 26092088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic-pharmacokinetic profiles of metformin hydrochloride from a mucoadhesive formulation of a polysaccharide with antidiabetic property in streptozotocin-induced diabetic rat models.
    Adikwu MU; Yoshikawa Y; Takada K
    Biomaterials; 2004 Jul; 25(15):3041-8. PubMed ID: 14967537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of once- or twice-daily extended release metformin compared with thrice-daily immediate release metformin in type 2 diabetes mellitus.
    Bhansali A; Masoodi SR
    J Assoc Physicians India; 2005 May; 53():441-5. PubMed ID: 16124352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taste-masking properties of solid lipid based micropellets obtained by cold extrusion-spheronization.
    Petrovick GF; Breitkreutz J; Pein-Hackelbusch M
    Int J Pharm; 2016 Jun; 506(1-2):361-70. PubMed ID: 27132502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and in vitro and in vivo characterization of mucoadhesive matrix pellets of metformin hydrochloride for oral controlled release: a technical note.
    Ige PP; Gattani SG
    Arch Pharm Res; 2012 Mar; 35(3):487-98. PubMed ID: 22477196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.